Company Info

Skyhawk

Drug Discovery & Development

Overview

About
Skyhawk Therapeutics is committed to discovering, developing and commercializing therapies that use its novel STAR* (Small molecule Therapies for Alternative splicing in RNA) platform to build small molecule drugs that bring breakthrough treatments to patients.

0 Contributors1 / 0

No authors found

1 / 0

3 Contributions1 / 1

Hematologic

Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers

Skyhawk

PR-11-24-NI-118Nov 21, 2024

Clinical Data

Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium

Skyhawk

PR-10-24-NI-62Oct 25, 2024

Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform

Skyhawk

PA4048Jun 28, 2018

1 / 1